First Patient Dosed in Chemotherapy Induced Peripheral Neuropathy Clinical Trial

Trial StartPositive

AI Analysis

Summary

Ananda Pharma Limited announced the first patient has been dosed in a clinical trial for a cannabidiol-based treatment for chemotherapy induced peripheral neuropathy. The company is a UK-based biopharmaceutical firm developing regulatory-approved cannabidiol medicines for complex chronic conditions.

Clinical Trial Data

Outcome Details

First patient dosed in CIPN clinical trial

Importance:3/10

Sentiment:

0.30

cannabidiolCIPNclinical trialUK biotechchronic disease

Related Companies

$TRAX

Read the original article

Published by PR Newswire Biotech on July 17, 2026 8:41 AM

Read Original